Proxy Votes Now

Home › Funds › Aspiriant Risk-Managed Equity Allocation Fund

Aspiriant Risk-Managed Equity Allocation Fund (RMEAX) proxy voting record 2025-2026

Fund family: Aspiriant Trust · Filed by Aspiriant Trust (CIK 1534881) · SEC series S000036290

Share classes and tickers: RMEAX (C000111026), RMEIX (C000111027)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,533 with, 87 against, 3 abstentions (not counted as with management); 41 items carried no recommendation; 8 split votes are in neither count. Shareholder proposals: 14 FOR, 72 AGAINST, 5 abstained, by the filing’s own vote-source field.

No item-level comparison with other Aspiriant Trust funds is possible: fewer than three other funds of the family voted in 2025-2026.

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections9660
Corporate Governance18321
Capital Structure1450
Compensation1212
Audit-related1070
Say-on-Pay630
Other Social Issues3527
Environment or Climate2220
Shareholder Rights and Defenses159
Extraordinary Transactions90

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Microsoft CorporationDecember 5, 2025$20M248
Apple Inc.February 24, 2026$18M201
Meta Platforms, Inc.May 27, 2026$16M3711
Amazon.com, Inc.May 20, 2026$12M174
Eli Lilly and CompanyMay 4, 2026$9M102
Lam Research CorporationNovember 4, 2025$9M161
Johnson & JohnsonApril 23, 2026$9M151
Alphabet Inc.June 5, 2026$8M2310

Notable votes against management

MeetingCompanyProposalFundMgmt
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
February 24, 2026Apple Inc.A shareholder proposal entitled "China Entanglement Audit" Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding report on Al data usage oversight. Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalForAgainst
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposalAgainstFor
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
November 4, 2025Lam Research CorporationStockholder proposal titled "Realistic Shareholder Ability to Call for a Special Shareholder Meeting," if properly presented. Shareholder proposalForAgainst
April 23, 2026Johnson & JohnsonIndependent Board Chair Shareholder proposalAgainstFor
June 5, 2026Alphabet Inc.Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposalAgainstFor

Search this fund’s votes by company

1,674 ballot items at 115 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Aspiriant Risk-Managed Equity Allocation Fund (RMEAX) voted at 115 shareholder meetings of 108 companies, on 1,674 ballot items in all. Where management made a recommendation, the fund followed it on 94.5% of the items and voted against it 87 times. Its most frequent area of disagreement was other social issues (27 of its votes against management). It voted FOR 16.3% of the 86 shareholder proposals on which it cast a FOR or AGAINST vote.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.